KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Other Working Capital Changes (2018 - 2025)

Historic Other Working Capital Changes for Aurinia Pharmaceuticals (AUPH) over the last 10 years, with Q3 2025 value amounting to -$997000.0.

  • Aurinia Pharmaceuticals' Other Working Capital Changes fell 15878.54% to -$997000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year increase of 40598.29%. This contributed to the annual value of $5.8 million for FY2024, which is 23159.81% up from last year.
  • Latest data reveals that Aurinia Pharmaceuticals reported Other Working Capital Changes of -$997000.0 as of Q3 2025, which was down 15878.54% from $11.2 million recorded in Q2 2025.
  • Over the past 5 years, Aurinia Pharmaceuticals' Other Working Capital Changes peaked at $11.2 million during Q2 2025, and registered a low of -$7.3 million during Q4 2023.
  • In the last 5 years, Aurinia Pharmaceuticals' Other Working Capital Changes had a median value of -$307000.0 in 2022 and averaged $462117.6.
  • Within the past 5 years, the most significant YoY rise in Aurinia Pharmaceuticals' Other Working Capital Changes was 46221.61% (2023), while the steepest drop was 166464.89% (2023).
  • Aurinia Pharmaceuticals' Other Working Capital Changes (Quarter) stood at -$1.2 million in 2021, then skyrocketed by 65.75% to -$413000.0 in 2022, then tumbled by 1664.65% to -$7.3 million in 2023, then soared by 97.09% to -$212000.0 in 2024, then crashed by 370.28% to -$997000.0 in 2025.
  • Its last three reported values are -$997000.0 in Q3 2025, $11.2 million for Q2 2025, and -$6.0 million during Q1 2025.